Adverse events of methotrexate treatment in JIA

by in ‘t Veld, J, Wulffraat, NM, Swart, JF
Published 2011

PReS-FINAL-2147: Immunological consequences of biologicals in juvenile idiopathic arthritis

by Swart, JF, De Roock, S, Wulffraat, NM
Published 2013

Early effects of Anakinra in corticosteroid naïve SOJIA patients

by Wulffraat, NM, de Jager, W, Prakken, B, Kuis, W
Published 2008

Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX

by Verkaaik, M, Bulatović, M, Sinnema, G, Rademaker, C, Wulffraat, NM
Published 2011

Measles, Mumps, Rubella serology in juvenile idiopathic arthritis

by Heijstek, MW, Berbers, GAM, van Gageldonk, PGM, Uiterwaal, CSP, Wulffraat, NM
Published 2008

PReS-FINAL-2181: Recombinant il-1ra restores the il-18-nk cell axis in steroid naive systemic juvenile idiopathic arthritis

by De Jager, W, Vastert, SJ, Mijnheer, G, Prakken, BJ, Wulffraat, NM
Published 2013

Single-nucleotide polymorphisms in the folate pathway are associated with response to methotrexate treatment in juvenile idiopathic arthritis

by Heijstek, MW, Wulffraat, NM, Eken, Y, Pluijm, SMF, Rademaker, CMA, de Jonge, R
Published 2008

Methotrexate does not primarily affect Foxp3+ regulatory T cells in poly-articular juvenile idiopathic arthritis

by Vastert, SJ, Verweij, FJ, de Jager, W, Wulffraat, NM, van Wijk, F, Prakken, BJ
Published 2008

Akinra restores the defective IL-18 NK cell axis in steroid naïve systemic onset JIA patients

by de Jager, W, Vastert, SJ, Noordman, BJ, Holzinger, D, Kuis, W, Prakken, BJ, Wulffraat, NM
Published 2011

Recombinant IL1-RA in the early phase of systemic onset JIA: before the onset of arthritis

by Vastert, SJ, De Jager, W, Noordman, BJ, Holzinger, D, Kuis, W, Prakken, BJ, Wulffraat, NM
Published 2011

4.5 Defective phosphorylation of the interleukin 18 receptor beta-chain causes impaired NK cell function in systemic onset Juvenile Idiopathic Arthritis

by de Jager, W, Vastert, SJ, Beekman, JM, Wulffraat, NM, Kuis, W, Coffer, PJ, Prakken, BJ
Published 2008

GNAS-associated disorders of cutaneous ossification: two different clinical presentations

by Schimmel, RJ, Pasmans, SGMA, Xu, M, Stadhouders-Keet, SAE, Shore, EM, Kaplan, FS, Wulffraat, NM
Published 2009

Safety and immunogenicity of human papillomavirus vaccination in juvenile patients with rheumatic diseases

by Heijstek, MW, Groot, N, Scherpenisse, M, Tacke, C, Berbers, G, van der Klis, F, Wulffraat, NM
Published 2011

Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis

by Boom, V., Anton, J., Lahdenne, P., Quartier, P., Ravelli, A., Wulffraat, N.M., Vastert, S.J.
Published in Pediatr Rheumatol Online J (2015)

Mesenchymal stem cells and JIA

by Swart, JF, de Roock, S, Hofhuis, F, Kuis, W, Prakken, BJ, Martens, AC, Slaper-Cortenbach, I, Wulffraat, NM
Published 2011

2.5 Mesenchymal Stem Cell Therapy has significant clinical effect in proteoglycan induced arthritis

by Swart, JF, Backer, MJG, Hofhuis, F, de Jager, W, Prakken, BJ, Kuis, W, Martens, ACM, Wulffraat, NM
Published 2008

Canakinumab treatment shows maintained efficacy in systemic juvenile idiopathic arthritis patients

by Wulffraat, NM, Ruperto, N, Brunner, HI, Oliveira, S, Uziel, Y, Nistala, K, Cimaz, R, Ferrandiz, MA, Flato, B, Gamir, M, Kone-Paut, I, Gaillez, C, Lheritier, K, Abrams, K, Martini, A, Lovell, D
Published 2014

Etanercept in juvenile idiopathic arthritis: Who will benefit?

by van den Berg JM, Swart JF, Dolman KM, Gorter SL, Koopman-Keemink Y, Twilt M, Hoppenreijs EPAH, ten Cate R, Armbrust W, Prince FHM, Otten MH, Wulffraat NM, van Rossum MAJ, van Suijlekom-Smit LWA
Published 2011-09-01

Etanercept in juvenile idiopathic arthritis: Who will benefit?

by Otten, MH, Prince, FHM, Armbrust, W, ten Cate, R, Hoppenreijs, EPAH, Twilt, M, Koopman-Keemink, Y, Gorter, SL, Dolman, KM, Swart, JF, van den Berg, JM, Wulffraat, NM, van Rossum, MAJ, van Suijlekom-Smit, LWA
Published 2011

Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a...

by Ruperto, N, Brunner, H, Horneff, G, Quartier, P, Constantin, T, Berkun, Y, Erguven, M, Kallinich, T, Brik, R, Wulffraat, NM, Ferrandiz, MA, Rutkowska-Sak, L, Ozdogan, H, McCann, L, Lheritier, K, Preiss, R, Tseng, L, Martini, A, Lovell, DJ
Published 2011